Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Daratumumab Overcome Platelet Transfusion Refractoriness in Patients with Aplastic Anemia: A Pilot Trail

Zhen Gao, Hong Pan, Jinbo Huang, Xin Zhao, Lele Zhang, Weiwang Li, Jianping Li, Neng Nie, Jingyu Zhao, Liyun Li, Jing Xu, Xiao Yu, Zhexiang Kuang, Meili Ge, Liwei Fang, Jun Shi

Blood (2024) 144 (Supplement 1): 4029.

https://doi.org/10.1182/blood-2024-204858

Published: 2024

Journal Articles

Cyclophosphamide Combined with Standard Immunosuppressive Therapy Improves Early Response Outcomes in Severe Aplastic Anemia

Hong Pan, Lele Zhang, Zhen Gao, Weiwang Li, Jianping Li, Neng Nie, Youzhen Xiong, Xin Zhao, Jinbo Huang, Jingyu Zhao, Xiao Yu, Zhexiang Kuang, Liwei Fang, Meili Ge, Weiping Yuan, Jun Shi

Blood (2024) 144 (Supplement 1): 5685.

https://doi.org/10.1182/blood-2024-205532

Published: 2024

Journal Articles

Anti-CD38 Monoclonal Antibody Is a Salvage Regimen in Relapsed/Refractory Aplastic Anemia

Weiwang Li, Lele Zhang, Hong Pan, Zhen Gao, Jianping Li, Neng Nie, Xin Zhao, Jinbo Huang, Jingyu Zhao, Xiao Yu, Zhexiang Kuang, Liwei Fang, Meili Ge, Weiping Yuan, Jun Shi

Blood (2024) 144 (Supplement 1): 2697.

https://doi.org/10.1182/blood-2024-207110

Published: 2024

Journal Articles

KDM6A regulates immune response genes in multiple myeloma

Daphné Dupéré-Richer, Alberto Riva, Benjamin G. Barwick, Sayantan Maji, Heidi Casellas Román, Jianping Li, Umasankar De, Amin Sobh, Gabrielle Quickstad, Crissandra Piper, Marta Kulis, Teresa Ezponda, José Ignacio Martín-Subero, Giovanni Tonon, Weizhou Zhang, Constantine S. Mitsiades, Lawrence H. Boise, Richard L. Bennett, Jonathan D. Licht

Blood (2024) 144 (14): 1508–1520.

https://doi.org/10.1182/blood.2024024518

Published: 2024

Includes: Supplemental data

Journal Articles

Activating NSD2 Mutations Drive Oncogenic Reprogramming By Disturbing Epigenetic Landscape in Mantle Cell Lymphoma

Jianping Li, Marta Kulis, Alberto Riva, Heidi Casellas Román, Daphne Dupere-Richer, Monica Clerio, Melanie L. Trejo, Michael Menes, Anthony Joseph Lamberto, Amin Sobh, Charlotte Leonie Kaestner, Richard Lynn Bennett, Iñaki I. Martin Subero, Jonathan D. Licht

Blood (2023) 142 (Supplement 1): 2771.

https://doi.org/10.1182/blood-2023-189748

Published: 2023

Journal Articles

Avatrombopag Is Effective in First-Line Treatment of Severe Aplastic Anemia: Early Outcomes of a Prospective Study

Xin Zhao, Jianping Li, Huihui Fan, Liping Jing, Li Zhang, Kang Zhou, Wenrui Yang, Yuan Li, Yang Yang, Lei Ye, Guangxin Peng, Youzhen Xiong, Jun Shi, Fengkui Zhang

Blood (2023) 142 (Supplement 1): 4087.

https://doi.org/10.1182/blood-2023-190948

Published: 2023

Journal Articles

Efficacy and Safety of Recombinant Thrombopoietin Combined with Immunosuppressive Therapy for Primary Treatment of Severe Aplastic Anemia: A Single-Center, Open-Label, Randomized, Clinical Trial

Wenrui Yang, Xin Zhao, Guangxin Peng, Huihui Fan, Kang Zhou, Lei Ye, Jianping Li, Yuan Li, Liping Jing, Li Zhang, Fengkui Zhang

Blood (2023) 142 (Supplement 1): 1348.

https://doi.org/10.1182/blood-2023-179958

Published: 2023

Journal Articles

Avatrombopag in Combination with Immunosuppressive Therapy for Hepatitis-Associated Aplastic Anemia

Wenrui Yang, Xin Zhao, Youzhen Xiong, Huihui Fan, Jianping Li, Lei Ye, Li Zhang, Liping Jing, Fengkui Zhang

Blood (2023) 142 (Supplement 1): 4091.

https://doi.org/10.1182/blood-2023-179722

Published: 2023

Journal Articles

Comparison of Hematopoietic Stem Cell Transplantation and Repeated Immunosuppressive Therapy As Second-Line Treatment for Relapsed/Refractory Severe Aplastic Anemia

Lining Zhang, Jianping Li, Weiru Liang, Jialin Wei, Yi He, Erlie Jiang, Fengkui Zhang, Mingzhe Han, Sizhou Feng

Blood (2023) 142 (Supplement 1): 7095.

https://doi.org/10.1182/blood-2023-179202

Published: 2023

Journal Articles

CRISPR-Based Gene-Editing Screens Revealed Modulators of Dexamethasone Sensitivity in Multiple Myeloma

Amin Sobh, Emilie Bonilla, Alisha Patel, Jianping Li, Mansi Dalal, Alberto Riva, Richard Lynn Bennett, Jonathan D. Licht

Blood (2023) 142 (Supplement 1): 6570.

https://doi.org/10.1182/blood-2023-179967

Published: 2023

Journal Articles

Anti-Human T Lymphocyte Porcine Immunoglobulin Combined with Cyclosporine As First-Line Immunosuppressive Therapy for Severe Aplastic Anemia in China: A Large Single-Center, 10-Year Retrospective Study

Wenrui Yang, Xu Liu, Xin Zhao, Li Zhang, Guangxin Peng, Lei Ye, Kang Zhou, Yuan Li, Jianping Li, Huihui Fan, Yang Yang, Youzhen Xiong, Liping Jing, Fengkui Zhang

Blood (2022) 140 (Supplement 1): 8655.

https://doi.org/10.1182/blood-2022-164574

Published: 2022

Journal Articles

Hematological Response to Avatrombopag Switch in Thrombopoietin Receptor Agonist-Refractory Aplastic Anemia

Liping Jing, Yingchang Mi, Huihui Fan, Wenrui Yang, Yuan Li, Jianping Li, Li Zhang, Xin Zhao, Kang Zhou, Lei Ye, Fengkui Zhang

Blood (2022) 140 (Supplement 1): 5811–5812.

https://doi.org/10.1182/blood-2022-168380

Published: 2022

Journal Articles

Immunosuppressive Therapy-Response Predicting Scoring System for Severe Aplastic Anemia

Xin Zhao, Li Zhang, Bing Han, Tiantian Zhang, Xu Liu, Miao Chen, Changping Li, Huijie Huang, Liping Jing, Kang Zhou, Guangxin Peng, Yuan Li, Jianping Li, Lei Ye, Huihui Fan, Wenrui Yang, Yingchang Mi, Fengkui Zhang

Blood (2022) 140 (Supplement 1): 5805–5806.

https://doi.org/10.1182/blood-2022-167951

Published: 2022

Journal Articles

Avatrombopag Added to Standard Immunosuppressive Therapy for Severe Aplastic Anemia

Xin Zhao, Baohang Zhang, Jianping Li, Huihui Fan, Yuan Li, Wenrui Yang, Liping Jing, Li Zhang, Kang Zhou, Youzhen Xiong, Lei Ye, Yingchang Mi, Fengkui Zhang

Blood (2022) 140 (Supplement 1): 2940.

https://doi.org/10.1182/blood-2022-169378

Published: 2022

Journal Articles

Hetrombopag Add to Porcine ATG and Cyclosporine for Aplastic Anemia: Early Outcomes of a Prospective Pilot Study

Wenrui Yang, Xin Zhao, Xu Liu, Youzhen Xiong, Huihui Fan, Guangxin Peng, Li Zhang, Jianping Li, Lei Ye, Kang Zhou, Yuan Li, Yang Yang, Yingchang Mi, Liping Jing, Fengkui Zhang

Blood (2022) 140 (Supplement 1): 8663.

https://doi.org/10.1182/blood-2022-166616

Published: 2022

Journal Articles

Functional CRISPR Screening Identifies Ptprg As a Driver of Migration and Adhesion in NSD2-E1099K ALL

Charlotte L Kaestner, Amin Sobh, Jianping Li, Alberto Riva, Richard Lynn Bennett, Jonathan D. Licht

Blood (2021) 138 (Supplement 1): 1149.

https://doi.org/10.1182/blood-2021-154009

Published: 2021

Journal Articles

Dysregulation of Epigenetic Landscape Uncovered the Mechanisms Underlying the Relapse of Pediatric Acute Lymphoblastic Leukemia with NSD2 Mutation

Jianping Li, Priscillia Lhoumaud, Alberto Riva, Crissandra Piper, Daphne Dupere-Richer, Heidi Casellas Roman, Amin Sobh, Charlotte L Kaestner, Alok Swaroop, Marta Kulis, Richard Lynn Bennett, Jane Skok, Jonathan D. Licht

Blood (2021) 138 (Supplement 1): 3297.

https://doi.org/10.1182/blood-2021-149985

Published: 2021

Journal Articles

Adenylate Kinase 2 Is a Selective Multiple Myeloma Cell Dependency That Is Preferentially Essential in NSD2-Overexpressing Cells

Amin Sobh, Charlotte L Kaestner, Jianping Li, Alberto Riva, Richard Lynn Bennett, Jonathan D. Licht

Blood (2021) 138 (Supplement 1): 1586.

https://doi.org/10.1182/blood-2021-153284

Published: 2021

Journal Articles

NSD2-E1099K Mutation Leads to Glucocorticoid-Resistant B Cell Lymphocytic Leukemia in Mice

Jianping Li, MD, Crissandra Piper, LATG, Daphne Dupere-Richer, PhD, Heidi Casellas Roman, MS, Alok Swaroop, PhD, Catalina Troche, PhD, Jon Oyer, PhD, Christine Will, MS, Alberto Riva, PhD, Richard Lynn Bennett, PhD, Jonathan D. Licht, MD

Blood (2020) 136 (Supplement 1): 3–4.

https://doi.org/10.1182/blood-2020-141295

Published: 2020

Journal Articles

Adenylate Kinase 2 Is a Selective Dependency in NSD2-High Multiple Myeloma

Amin Sobh, PhD, Charlotte Kaestner, Jianping Li, MD, Alberto Riva, PhD, Richard Lynn Bennett, PhD, Jonathan D. Licht, MD

Blood (2020) 136 (Supplement 1): 31.

https://doi.org/10.1182/blood-2020-141266

Published: 2020

NARROW

Daratumumab Overcome Platelet Transfusion Refractoriness in Patients with Aplastic Anemia: A Pilot Trail

Cyclophosphamide Combined with Standard Immunosuppressive Therapy Improves Early Response Outcomes in Severe Aplastic Anemia

Anti-CD38 Monoclonal Antibody Is a Salvage Regimen in Relapsed/Refractory Aplastic Anemia

KDM6A regulates immune response genes in multiple myeloma

Activating NSD2 Mutations Drive Oncogenic Reprogramming By Disturbing Epigenetic Landscape in Mantle Cell Lymphoma

Avatrombopag Is Effective in First-Line Treatment of Severe Aplastic Anemia: Early Outcomes of a Prospective Study

Efficacy and Safety of Recombinant Thrombopoietin Combined with Immunosuppressive Therapy for Primary Treatment of Severe Aplastic Anemia: A Single-Center, Open-Label, Randomized, Clinical Trial

Avatrombopag in Combination with Immunosuppressive Therapy for Hepatitis-Associated Aplastic Anemia

Comparison of Hematopoietic Stem Cell Transplantation and Repeated Immunosuppressive Therapy As Second-Line Treatment for Relapsed/Refractory Severe Aplastic Anemia

CRISPR-Based Gene-Editing Screens Revealed Modulators of Dexamethasone Sensitivity in Multiple Myeloma

Anti-Human T Lymphocyte Porcine Immunoglobulin Combined with Cyclosporine As First-Line Immunosuppressive Therapy for Severe Aplastic Anemia in China: A Large Single-Center, 10-Year Retrospective Study

Hematological Response to Avatrombopag Switch in Thrombopoietin Receptor Agonist-Refractory Aplastic Anemia

Immunosuppressive Therapy-Response Predicting Scoring System for Severe Aplastic Anemia

Avatrombopag Added to Standard Immunosuppressive Therapy for Severe Aplastic Anemia

Hetrombopag Add to Porcine ATG and Cyclosporine for Aplastic Anemia: Early Outcomes of a Prospective Pilot Study

Functional CRISPR Screening Identifies Ptprg As a Driver of Migration and Adhesion in NSD2-E1099K ALL

Dysregulation of Epigenetic Landscape Uncovered the Mechanisms Underlying the Relapse of Pediatric Acute Lymphoblastic Leukemia with NSD2 Mutation

Adenylate Kinase 2 Is a Selective Multiple Myeloma Cell Dependency That Is Preferentially Essential in NSD2-Overexpressing Cells

NSD2-E1099K Mutation Leads to Glucocorticoid-Resistant B Cell Lymphocytic Leukemia in Mice

Adenylate Kinase 2 Is a Selective Dependency in NSD2-High Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only